Browsing byAuthorSim, Taebo

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 30 of 89

Issue DateTitleAuthor(s)
2010-06-151,4-Dihydropyrazolo[4,3-d]imidazole phenyl derivatives: A novel type II Raf kinase inhibitorsYu, Hana; Jung, Yunkyung; Kim, Hwan; Lee, Junghun; Oh, Chang-Hyun; Yoo, Kyung Ho; Sim, Taebo; Hah, Jung-Mi
2019-05A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic PainSong, Gyun Jee; Rahman, Md Habibur; Jha, Mithilesh Kumar; Gupta, Deepak Prasad; Park, Sung Hee; Kim, Jae-Hong; Lee, Sun-Hwa; Lee, In-Kyu; Sim, Taebo; Bae, Yong Chul; Lee, Won-Ha; Suk, Kyoungho
2015-06A Concise and Efficient Total Synthesis of Militarinone DDash, Uttam; Sengupta, Sandip; Sim, Taebo
2014-08A Concise Synthesis of Mupirocin H Using a Cross-Metathesis-Based StrategySengupta, Sandip; Sim, Taebo
2013-06A new quantum dot-platinum conjugate for self-assembled nanoconjugates by coordination bonding mediated recognitionLee, Jiyeon; Kim, Heeyeon; Sim, Taebo; Song, Rita
2016-01-14A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper MutantsYoon, Hojong; Kwak, Yeonui; Choi, Seunghye; Cho, Hanna; Kim, Nam Doo; Sim, Taebo
2010-08-12A Type-II Kinase Inhibitor Capable of Inhibiting the T315I "Gatekeeper" Mutant of Bcr-AblChoi, Hwan Geun; Ren, Pingda; Adrian, Francisco; Sun, Fangxian; Lee, Hyun Soo; Wang, Xia; Ding, Qiang; Zhang, Guobao; Xie, Yongping; Zhang, Jianming; Liu, Yi; Tuntland, Tove; Warmuth, Markus; Manley, Paul W.; Mestan, Juergen; Gray, Nathanael S.; Sim, Taebo
2016-12Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerBahcall, Magda; Sim, Taebo; Paweletz, Cloud P.; Patel, Jyoti D.; Alden, Ryan S.; Kuang, Yanan; Sacher, Adrian G.; Kim, Nam Doo; Lydon, Christine A.; Awad, Mark M.; Jaklitsch, Michael T.; Sholl, Lynette M.; Jaenne, Pasi A.; Oxnard, Geoffrey R.
2018-02Amphiphilic small peptides for delivery of plasmid DNAs and siRNAsBang, Eun-Kyoung; Cho, Hanna; Jeon, Sean S. -H.; Na Ly Tran; Lim, Dong-Kwon; Hur, Wooyoung; Sim, Taebo
2010-09-22An efficient and enantioselective total synthesis of naturally occurring L-783277Choi, Hwan Geun; Son, Jung Beom; Park, Dong-Sik; Ham, Young Jin; Hah, Jung-Mi; Sim, Taebo
2013-10-23An efficient synthesis of 1,4-dideoxy-1,4-imino-D- and L-arabinitol and 1,4-dideoxy-1,4-imino-D- and L-xylitol from chiral aziridinesChoi, Hwan Geun; Park, Dong-Sik; Lee, Won Koo; Sim, Taebo
2020-12-15Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockersChoi, Seung-Hye; Ryu, SeongShick; Sim, Kyoungmi; Song, Chiman; Shin, Injae; Kim, Seong-Seop; Lee, Young-Sun; Park, Jae-Yong; Sim, Taebo
2017-06-14Anti-leukemia activity of a Hsp70 inhibitor and its hybrid moleculesPark, Seong-Hyun; Kim, Won-Je; Li, Hui; Seo, Wonil; Park, Sang-Hyun; Kim, Hwan; Shin, Sang Chul; Zuiderweg, Erik R. P.; Kim, Eunice EunKyeong; Sim, Taebo; Kim, Nak-Kyoon; Shin, Injae
2015-10Antitumor Effects and Mechanisms of AZD4547 on FGFR2-Deregulated Endometrial Cancer CellsKwak, Yeonui; Cho, Hanna; Hur, Wooyoung; Sim, Taebo
2016-01Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutationsKim, Do-Hee; Kwak, Yeonui; Kim, Nam Doo; Sim, Taebo
2014-04-15Asymmetric synthesis of (+)-lentiginosine using a chiral aziridine based approachYoon, Hojong; Cho, Kyung Seon; Sim, Taebo
2017-09-15Characterization of a highly selective inhibitor of the Aurora kinasesFerguson, Fleur M.; Doctor, Zainab M.; Chaikuad, Apirat; Sim, Taebo; Kim, Nam Doo; Knapp, Stefan; Gray, Nathanael S.
2010-11-30Chemical kinomics: a powerful strategy for target deconvolutionKim, Do-Hee; Sim, Taebo
2024-06Correction: Nam et al. Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance. Cancers 2023, 15, 143Nam, Yunju; Kim, Chan; Han, Junghee; Ryu, SeongShick; Cho, Hanna; Song, Chiman; Kim, Nam Doo; Kim, Namkyoung; Sim, Taebo
2017-01Covalent Guanosine Mimetic Inhibitors of G12C KRASXiong, Yuan; Lu, Jia; Hunter, John; Li, Lianbo; Scott, David; Choi, Hwan Geun; Lim, Sang Min; Manandhar, Anuj; Gondi, Sudershan; Sim, Taebo; Westover, Kenneth D.; Gray, Nathanael S.
2015-07Design and Synthesis of New [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Potential Antiproliferative AgentsElkamhawy, Ahmed; Al-Sanea, Mohammad M.; Song, Chiman; Sim, Taebo; Roh, Eun Joo
2011-08Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell linesEl-Gamal, Mohammed I.; Jung, Myung-Ho; Lee, Woong San; Sim, Taebo; Yoo, Kyung Ho; Oh, Chang-Hyun
2012-07-01Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2Jung, Myung-Ho; El-Gamal, Mohammed I.; Abdel-Maksoud, Mohammed S.; Sim, Taebo; Yoo, Kyung Ho; Oh, Chang-Hyun
2018-12-15Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitorsChoi, Min Jung; Roh, Eun Joo; Hur, Wooyoung; Lee, So Ha; Sim, Taebo; Oh, Chang-Hyun; Lee, Sun-Hwa; Kim, Jong Seung; Yoo, Kyung Ho
2012-08-15Development of 'DFG-out' inhibitors of gatekeeper mutant kinasesChoi, Hwan Geun; Zhang, Jianming; Weisberg, Ellen; Griffin, James D.; Sim, Taebo; Gray, Nathanael S.
2019-06Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeOlson, Calla M.; Liang, Yanke; Leggett, Alan; Park, Woojun D.; Li, Lianbo; Mills, Caitlin E.; Elsarrag, Selma Z.; Ficarro, Scott B.; Zhang, Tinghu; Duester, Robert; Geyer, Matthias; Sim, Taebo; Marto, Jarrod A.; Sorger, Peter K.; Westover, Ken D.; Lin, Charles Y.; Kwiatkowski, Nicholas; Gray, Nathanael S.
2016-08Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoSundberg, Thomas B.; Liang, Yanke; Wu, Huixian; Choi, Hwan Geun; Kim, Nam Doo; Sim, Taebo; Johannessen, Liv; Petrone, Adam; Khor, Bernard; Graham, Daniel B.; Latorre, Isabel J.; Phillips, Andrew J.; Schreiber, Stuart L.; Perez, Jose; Shamji, Alykhan F.; Gray, Nathanael S.; Xavier, Ramnik J.
2014-11-11Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsTan, Li; Wang, Jun; Tanizaki, Junko; Huang, Zhifeng; Aref, Amir R.; Rusan, Maria; Zhu, Su-Jie; Zhang, Yiyun; Ercan, Dalia; Liao, Rachel G.; Capelletti, Marzia; Zhou, Wenjun; Hur, Wooyoung; Kim, NamDoo; Sim, Taebo; Gaudet, Suzanne; Barbie, David A.; Yeh, Jing-Ruey Joanna; Yun, Cai-Hong; Hammerman, Peter S.; Mohammadi, Moosa; Jaenne, Pasi A.; Gray, Nathanael S.
2018-06Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8Hatcher, John M.; Wang, Eric S.; Johannessen, Liv; Kwiatkowski, Nicholas; Sim, Taebo; Gray, Nathanael S.
2010-03-01Discovery and initial SAR of pyrimidin-4-yl-1H-imidazole derivatives with antiproliferative activity against melanoma cell linesLee, Junghun; Kim, Hwan; Yu, Hana; Chung, Jae Yoon; Oh, Chang-Hyun; Yoo, Kyung Ho; Sim, Taebo; Hah, Jung-Mi

BROWSE